No Detail Found!

Spectrophotometric method for the determination of Gemifloxacin mesylate in pure and tablet dosage form.

Author(s)
Syed Saeed-Ul-Hassan University College of Pharmacy, University of the Punjab, Lahore, Pakistan
Uzma Hayat University College of Pharmacy, University of the Punjab, Lahore, Pakistan
Imran Tariq University College of Pharmacy, University of the Punjab, Lahore, Pakistan
Irshad Ahmad Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
Muhammad Munawar Hayat Department of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
Muhammad Uzair Department of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
Muhammad Tayyab Ansari Department of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
Abstract
A spectrophotometric method for the determination of Gemifloxacin mesylate (GFX) is developed and validated according to ICH guidelines. GFX is a fluoroquinolone that is used in the treatment of pneumonia. The analysis of the pure drug was carried out at its λmax 270 nm. The method was linear from 0.5-5µg/mL, r2 0.999 and equation is 0.102-0.000. The % RSD for inter-day (0.969%) and intra-day (0.714%) assuring a good precision and accuracy was close to 100%. Limit of detection and Limit of quantification were 0.197 and 0.599µg/mL, respectively. The validation results and statistical data demonstrate that the method is accurate, sensitive, cost effective and reproducible and has an importance in quality assurance of GFX analysis. The developed method was proved suitable for analysis of GFX in the pure and tablet dosage forms without interference of excepients.
Publication Details
Page(s) 1171-1174
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 27, Issue: 5, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

95

Views